New options for influenza vaccines: quadrivalent, recombinant, and cell culture. | J Am Pharm Assoc (2003);53(5): 545-9, 2013. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

New options for influenza vaccines: quadrivalent, recombinant, and cell culture.

Brokhof, Marissa M; Foster, Stephan L; Hayney, Mary S.

J Am Pharm Assoc (2003) ; 53(5): 545-9, 2013.

Article in En | MEDLINE | ID: mdl-24030133

Subject(s)

Influenza Vaccines/administration & dosage; Influenza, Human/prevention & control; Cell Culture Techniques; Humans; Influenza A Virus, H1N1 Subtype/immunology; Influenza A Virus, H3N2 Subtype/immunology; Influenza B virus/immunology; Influenza Vaccines/immunology; Influenza, Human/epidemiology; Influenza, Human/immunology; Vaccines, Synthetic/immunology

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Limits: Humans Language: En Journal: J Am Pharm Assoc (2003) Journal subject: FARMACIA Year: 2013 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Limits: Humans Language: En Journal: J Am Pharm Assoc (2003) Journal subject: FARMACIA Year: 2013 Document type: Article